Volume | 325,560 |
|
|||||
News | - | ||||||
Day High | 9.55 | Low High |
|||||
Day Low | 9.15 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Nevro Corp | NVRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.25 | 9.15 | 9.55 | 9.27 | 9.45 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5,039 | 325,560 | US$ 9.31 | US$ 3,031,281 | - | 8.93 - 26.63 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 39,446 | US$ 9.27 | USD |
Nevro Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
336.68M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nevro News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.30 | 9.78 | 9.07 | 9.33 | 410,819 | -0.03 | -0.32% |
1 Month | 10.59 | 11.65 | 8.93 | 9.90 | 551,237 | -1.32 | -12.46% |
3 Months | 13.74 | 14.70 | 8.93 | 11.39 | 517,662 | -4.47 | -32.53% |
6 Months | 19.01 | 22.64 | 8.93 | 14.98 | 518,965 | -9.74 | -51.24% |
1 Year | 23.48 | 26.63 | 8.93 | 17.65 | 544,113 | -14.21 | -60.52% |
3 Years | 148.57 | 182.45 | 8.93 | 50.41 | 553,489 | -139.30 | -93.76% |
5 Years | 61.61 | 188.14 | 8.93 | 74.21 | 492,521 | -52.34 | -84.95% |
Nevro Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |